Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Head and Neck Neoplasms × Indocyanine Green × Clear all

Phase

Status

Completed 4 Unknown 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Neoplasms 3 Stomach Neoplasms 2 Sarcoma 2 Lymphatic Metastasis 2 Lung Neoplasms 2 Giant Cell Tumor of Bone 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Sarcoma, Ewing 1 Right Hemicolectomy 1 Rhabdomyosarcoma 1 Parathyroid Diseases 1 Osteosarcoma 1 Neuroblastoma 1 Mesothelioma, Malignant 1 Melanoma 1 Lymphoma 1 Inflammatory Breast Neoplasms 1 Head and Neck Neoplasms 1 Giant Cell Tumor of Tendon Sheath 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinosarcoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Breast Cancer Lymphedema 1

Interventions

pembrolizumab 23 Cisplatin 14 Carboplatin 13 Radiotherapy 12 Blood Specimen Collection 10 Paclitaxel 9 Cetuximab 8 Fluorouracil 7 Docetaxel 7 Drug Therapy 5 toripalimab 4 atezolizumab 4 Radiation 4 tislelizumab 3 Surgical Procedures, Operative 3 Chemoradiotherapy 3 Biopsy 3 cemiplimab 2 avelumab 2 Tocopherols 2 Tiragolumab 2 Tablets 2 Surveys and Questionnaires 2 Standard of Care 2 Riluzole 2 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 Pravastatin 2 Pentoxifylline 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04842162 2025-11-26

MAGNOLIA

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Recruiting

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡